pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›OXYCONTIN
drug
save

OXYCONTIN

updated 3mo ago
by Purdue Pharma LP
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval588 co-mentions · 259 sources
  • drugOXYCODONE HYDROCHLORIDE403 co-mentions · 260 sources
  • drugROXICODONE307 co-mentions · 260 sources
  • drugoxycodone ER295 co-mentions · 260 sources
  • drugoxycodone hydrochloride ER295 co-mentions · 260 sources
  • drugXTAMPZA ER295 co-mentions · 260 sources
  • tagSmall Molecule294 co-mentions · 259 sources
  • drugOXYCODONE HYDROCHLORIDE AND IBUPROFEN111 co-mentions · 37 sources

all catalysts(0)

nothing on the calendar yet

Trials studying OXYCONTIN

  • phase23D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Painnot yet recruitingn=177
  • phase1A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjectscompletedn=20
  • phase1Evaluation of Oral PF614 Relative to OxyContin (PF614-102)completedn=84
  • phase1A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)completedn=32

News(3)

  • Super-potent synthetic opioids called nitazenes are spreading across the U.S.
    Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDC
    stat · 2mo ago
  • ‘Forever chemicals’ in baby formula? Scientists unpack FDA results
    FDA review confirmed overall safety of 16 brands of baby formula. In a STAT Q&A, experts unpack what low-level PFAS findings mean to worried moms.
    stat · 3mo ago
  • STAT+: OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
    At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent years dealing with addiction treatment.
    stat · 3mo ago
brand
OXYCONTIN
generic
OXYCODONE HYDROCHLORIDE
Data sources
ClinicalTrials.gov
last refreshed 13m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?